glp-1/gip/gcg receptor agonist LY3437943, a novel triple glucagon, GIP, and GLP-1 for glycemic control and weight loss: From discovery to clinical proof of concept LY3437943, a novel triple glucagon,

New content online: The role of GLP1 receptor agonists in adult-onset type 1 diabetes mellitus

Rapid weight loss with GLP1 receptor agonists can come at the cost of skeletal muscle, potentially undermining metabolic and functional outcomes

International Online Medical Council journals provide an efficacious channel for researchers, students, and faculty members to publish works while maintaining excellence in medical research.

Clinicians should maintain heightened awareness for aspiration risk in perioperative settings

While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives

The GLP-1 Receptor Agonist market size reached USD 15.25 Billion in 2024 and is expected to register a revenue CAGR of 21.7%